Category: Peripheral Intervention

Merit Medical Soft Tissue Biopsy Solutions: Retrieving Samples with Confidence

Soft-Tissue Biopsy Systems - Achieve, Temno, Tru-CutOur goal at Merit Medical is to provide the highest-quality medical devices, equipping you to deliver effective diagnosis and treatment. One area of patient care where high-quality devices are crucial is biopsy procedures. Biopsies are critical tools in the diagnostic process. They help determine the presence and extent of disease and are significant to developing appropriate care plans. 

To help clinicians like you perform biopsy procedures accurately, safely, and with confidence, we offer a wide range of advanced soft tissue biopsy products. From the recently launched TEMNO Elite™ Biopsy System to high-quality legacy products, browse to find the products that best meet your clinical needs:


TEMNO Elite ™ Biopsy System

Temno ELITE - Built for Better Biopsy - Merit Medical

The new TEMNO Elite Biopsy System is designed to provide you with superior soft tissue samples and total control during procedures. Its advanced features allow for samples 72% larger than competitor side-notch, semi-automatic devices.1 Available in a variety of sizes, the TEMNO Elite is ideal for procedures in many parts of the body, including kidney, liver, and lung.

Achieve® Programmable Automatic Biopsy System

Achieve Automatic Biopsy Device

With just one hand, you can now benefit from the precise control and quality sampling capability of the Achieve Programmable Automatic Biopsy System. This lightweight, automatic device is spring-loaded for fast, accurate penetration when working with calcified or fibrous lesions. For more precision, the Achieve offers three programmable firing modes.

Pink Achieve™ Biopsy Device

Pink Achieve Biopsy Device

The easy-to-use, lightweight design of the Pink Achieve Biopsy Device allows you one-handed use and convenient ultrasound transducer manipulation during breast biopsies. Visualize needle placement before sample retrieval by using the delayed firing option. A coaxial introducer enables multiple sampling from one percutaneous puncture, minimizing damage to surrounding tissue.

Adjustable Coaxial TEMNO™ (ACT) Biopsy Device

The ACT Biopsy Device allows you to adjust sample size for precise control when working with small lesions and in vascular areas. Reposition the stylet prior to sample capture for greater confidence. Echogenic markings facilitate precise ultrasound placement.

Original TEMNO™ Biopsy Device

Original TEMNO™ Biopsy Device - Merit Medical

Our Original TEMNO Biopsy Device features a 20-mm sample notch for quality sample retrieval and comes in a variety of sizes and gauges. With a sharp bevel tip and depth marks every centimeter (including echogenic markings), it allows you to complete precise sampling for breast, kidney, liver, lung, and thyroid biopsies.

TEMNO Evolution® Biopsy Device

Temno Evolution® Biopsy Device

Merit’s TEMNO Evolution Biopsy Device features two notch sizes (10 mm or 20 mm) for clinical flexibility and precise sampling. Its compact, ergonomic design and tactile-enhanced plunger support increased comfort and one-handed operation. The coaxial introducer allows you to collect multiple samples from a single puncture with minimal damage to surrounding tissue.

Tru-Cut® Biopsy Device

Tru-Cut Biopsy Device

Manually capture samples with minimal patient trauma using the Tru-Cut Biopsy Device. It features a 20-mm specimen notch, a thin-wall needle to yield a larger core, and removable stylet to obtain multiple tissue samples. Centimeter depth markings assist in needle placement.


At Merit, we’re dedicated to providing high-quality biopsy solutions that help you care for your patients. By working closely with healthcare providers to understand clinical needs, we can innovate new devices and deliver improvements to existing technology to better the patient experience. Talk to your Merit Representative or contact Customer Support to discuss how you can incorporate Merit’s biopsy products into your practice today.

REFERENCES

  1. Internal testing with 18G. Data on File. Marketing Claims for the TEMNO Elite Device (ECN147270).
  2. 18 Gauge, Data on file, Merit Medical, 2015.

Merit Medical to Exhibit at CIRSE 2022

Colorful view of Barcelona, Spain with white text on a blue background - Join Us at CIRSEMerit Medical will be exhibiting at CIRSE 2022, the Cardiovascular and Interventional Radiological Society of Europe’s Annual Congress. Join our team September 10-13 in Barcelona, Spain, for a high-quality, four-day educational program with an international audience, in-person training, and hands-on workshops.

This year, we’re hosting a valuable Satellite Symposium as well as daily Learning Center Program sessions with topics tailored to meet a wide range of clinical needs. We also have an exciting lineup of leading-edge products designed to improve patient outcomes.

Here’s a summary of what you can expect from us at CIRSE 2022:


Satellite Symposium

Listen in on this valuable panel discussion featuring thought leaders from across the globe. Lunch bags will be provided.

Topic:
Expanding Patient Access with Merit WRAPSODY™, the Cell-Impermeable Endoprosthesis Designed to Meet the Clinical Challenges of AVF & AVG Interventions

Maintain Long-Term Vessel Patency - Merit WRAPSODYDate: September 13, 2022

Time: 13:00-14:00 CEST

Location: Room 115

Lectures and Faculty 

WRAPSODY Cell-Impermeable Endoprosthesis: Why Develop the Next Generation Covered Stent?

Dr. Bart Dolmatch (Mountain View, USA)

Recorded Case: Successful Treatment of a Challenging AV Stenosis with WRAPSODY Cell-Impermeable Endoprosthesis

Dr. Tobias Steinke (Düsseldorf/DE)

Case Presentations—the Value of WRAPSODY Cell-Impermeable Endoprosthesis in Treating Challenging AV Dysfunctions—Part 1

Dr. Ounali Jaffer (London/UK)

Case Presentations—the Value of WRAPSODY Cell-Impermeable Endoprosthesis in Treating Challenging AV Dysfunctions—Part 2

Prof. Fabrizio Fanelli (Florence/IT)

Case Presentations—How I Reduce Reintervention Rates in My Practice with WRAPSODY Cell-Impermeable Endoprosthesis

Dr. Thiago Barroso (Brasilia/BR)

Learning Objectives

  • Explore how experts utilize the features of WRAPSODY for optimal clinical outcomes.
  • Discover the benefits of using a cell-impermeable endoprosthesis through challenging real-case discussions.  
  • Understand the economic impact of using a cell-impermeable endoprosthesis at early stages.

The Merit Learning Center

Explore the following daily lectures and hands-on sessions. Please join us early; space is limited!

REGISTER NOW TO ATTEND >>

TOPICFACULTYDATE / TIMESOBJECTIVE
Embolize with Experts ǀ UAE Latest News. Ovarian Protection, Fertility & AdenomyosisDr. Olivier Serres Cousiné (Montpellier/FR)
Dr Olivier Serres Cousiné
Sat, Sept 10, 2022
– 13:30–14:15 CEST
Explore the latest clinical evidence on uterine artery embolization.
Embolize with Experts ǀ 1st International Prostate Registry: What Are the Clinical Data Telling Us?Prof. Marc Sapoval (Paris/FR)
Prof. Marc Sapoval
Sat, Sept 10, 2022
– 15:00-15:45 CEST
Review preliminary results of a prostate multicenter registry, followed by a “How I Do It” discussion.
The Art of dTRA ǀ Distal Radial Access Technique in Peripheral InterventionDr. Darren Klass
(Vancouver/CA)
Dr Darren Klass
Sun, Sept 11, 2022
– 09:00–09:45 CEST
– 11:00–11:45 CEST
Discuss why choosing distal transradial access first expands access options for interventionalists in peripheral procedures. Discover best practices in distal radial access and hemostasis and how this improves patient care.
Advanced Outcomes Made Simple ǀ Liver and Lung Biopsy with the New TEMNO Elite™ NeedleDr. Damian Mullan (Manchester/UK)
Dr Damian Mullan
Sun, Sept 11, 2022
– 13:30–14:15 CEST
– 15:00–15:45 CEST
Explore unique key features of the new TEMNO Elite Biopsy System and how these will benefit liver and lung biopsy procedures.
The Art of dTRA ǀ Distal First: Advancing Vascular AccessDr. Ferdinand Kiemeneij (Tergooi/NL)
Dr. Ferdinand Kiemeneij
Mon, Sept 12, 2022
– 09:00–09:45 CEST
– 11:00–11:45 CEST
Discuss choosing distal transradial access as a first option. Review data and literature highlighting why it should be the default vascular access site and its safety.
Advanced Outcomes Made Simple ǀ Swift Decision Making: When SwiftNINJA® Should Be Used to Overcome Tricky ProceduresProf. Mark Little (Berkshire/UK)
Prof Mark Little
Mon, Sept 12, 2022
– 13:30–14:15 CEST
Find how using SwiftNINJA first will simplify and shorten procedures.
Maximum Results. Fast Recovery ǀ Venous Leg Ulcer: NTNT Treatment OptionMr. Leith Williams (Wirral/UK)
Mr Leith Williams
Tues, Sept 13, 2022
– 09:00–09:45 CEST
– 11:00–11:45 CEST
Explore an innovative approach to treating venous leg ulcers, including the benefits of treating advanced venous disease with non-thermal, non-tumescent technique.

REGISTER NOW TO ATTEND >>


Hands-on Device Training

Discover multiple exclusive sessions organized by CIRSE.

Learning Objectives

  • Discover available devices and technical specifications for the given topic.
  • Obtain basic knowledge about the manipulation of the different devices.

Sessions and Faculty

TOPICFACULTYDATE / TIMESLOCATION
Tumor Ablation (RFA)Prof. Jean-Yves Gaubert (Marseille/FR) and Dr. Maria Tsitskari (Nicosia/CY)Sun, Sept 11, 2022
– 09:45-11:15 CEST
– 12:45-14:15 CEST
– 17:30-18:30 CEST
Room 111
Vertebral AugmentationDr. Paul N.M. Lohle (Tilburg/NL) and Prof. Kai E. Wilhelm (Bonn/DE)Mon, Sept12, 2022
– 09:45-11:15 CEST
– 12:45-14:15 CEST
Room 132
Embolization: Materials & Tools (Particulate Agents)Prof. Bernhard Gebauer (Berlin/DE) and Prof. Stavros Spiliopoulos (Athens/GR)Tues, Sept 13, 2022
– 09:45-11:15 CEST
– 12:45-14:15 CEST
Room 134
Varicose VeinsDr. John M. Regi (Sheffield/GB) and Dr. Filipe Veloso Gomes (Lisbon/PT)Tues, Sept 13, 2022
– 09:45-11:15 CEST
– 12:45-14:15 CEST
Room 132

Advanced Merit Technologies

Visit us at the Merit booth 47 and the Learning Center to explore what our advanced technologies can bring to your procedures.

Sample Assist - Biopsy Samples with the Push of a Button - TEMNO Elite Biopsy System - Merit MedicalTEMNO Elite Biopsy System

Achieve superior samples with the TEMNO Elite Biopsy System, a device that obtains samples 72% larger than competitor side-notch, semi-automatic devices.1

Explore More >>

Syringes of Embosphere Microspheres shownEmbosphere® Microspheres

The most clinically studied spherical embolic, Embosphere is the clear choice among interventional radiologists. Designed for predictable and durable occlusion for the embolisation of symptomatic uterine fibroids, ABMs, and hypervascular tumours, the elastic material allows for temporary compression of up to 33%,3 yielding targeted results for patients and practitioners.

Discover More about the Embosphere >>

SwiftNINJA® Steerable Microcatheter

The SwiftNINJA is an innovative straight-tip catheter featuring an ergonomic steering dial that navigates up to 180 degrees and enables in vivo control. Consisting of a hydrophilic-coated distal 80 cm, the device delivers exceptional precision and speed navigating even in the most challenging vascular ostium.

Learn More about SwiftNINJA >>

ClariVein OC - treatment for endovenous mechanochemical ablationClariVein® OC Infusion Catheter

A minimally invasive solution for patients, the ClariVein OC Infusion Catheter features a unique 360-degree rotatable dispersion wire at the distal end. The catheter design has been engineered with a small profile, exceptional flexibility, strong imaging visualisation, and excellent pushability.

Please Note: The ClariVein OC Infusion Catheter is not available for sale or use within the United States.

Explore the ClariVein OC >>

Maintain Long-Term Vessel Patency - Merit WRAPSODYMerit WRAPSODY Cell-Impermeable Endoprosthesis

Featuring a unique tri-layered endoprosthesis microstructure, the Merit WRAPSODY Cell-Impermeable Endoprosthesis extends long-term vessel patency in patients who experience obstructions in the dialysis outflow circuit. The hydrophilic coating allows pinpoint accuracy, smooth insertion, and withdrawal with top-tier trackability.

Please Note: The Merit WRAPSODY Cell-Impermeable Endoprosthesis is not available for sale or use within the United States.

Discover More >>


We look forward to meeting you at CIRSE 2022 and discussing how our products and services can bring advantages to your practice. See you in Barcelona!

Questions? Contact our Customer Support Center, and speak to one of our representatives. Live chat, phone, or email—we’re here for you. 

Don’t forget to follow us on social media for live conference updates!

Follow Merit on LinkedIn
Follow Merit on Twitter
Follow Merit on YouTube

Before using any of the Merit products mentioned above, refer to Instructions for Use for indications, contraindications, warnings, precautions, and directions for use.


REFERENCES

  1. Internal testing with 18G. Data on File. Marketing Claims for the TEMNO Elite Device (ECN147270).

Carmen’s Journey with Fibroids and Finding Relief in UFE

Uterus with Fibroids Present - Fibroid Awareness Month - JulyJuly is Fibroid Awareness Month, a time we recognize a health issue affecting as many as 80 percent of women before they reach the age of 50.1 Fibroids, or muscular tumors that develop in the wall of the uterus, are more common among African Americans than white, Hispanic, or Asian women.1 Generally noncancerous, they can range in size from a small apple seed to a large grapefruit.2

Although some women with fibroids have no symptoms, others may experience abdominal pain, frequent urination, enlargement of the lower abdomen, and heavy menstrual bleeding.2 Despite its prevalence and severe symptoms, the condition is seldom discussed. To change that, we talked with Carmen McKeever, who was first diagnosed with uterine fibroids during an appointment with her gynecologist.

Carmen McKeever - Diagnosed with Uterine FibroidsAt first, Carmen didn’t think anything of her fibroids, but a few years later, she developed serious symptoms, including heavy, long, painful periods—including a devastating cycle that caused her to bleed for an entire month straight.

“Fibroids really impacted my everyday life.” Carmen explained. “Professionally, I am a nurse. At my facility, our uniform is white scrubs. So you can imagine, every month it was like a nightmare.”

During her period, Carmen had to equip herself with an “arsenal” to make it through the day and avoid accidents. On any given day, she admitted to needing a super absorbency tampon, two ultra-absorbency maxi-pads, a Depend® adult diaper, and Spanx® to hold it all together.

All of this wasn’t enough, as Carmen explained. “I also had all that stuff in my bag just in case I had to change, which was about every hour.”

Unable to tolerate going through life like this any longer, Carmen explored fibroid treatments. But like other women seeking an alternative to a complete hysterectomy, Carmen faced resistance when meeting with doctors.

“The help I received from medical professionals was—operate. Hysterectomy. That was it. I just felt like I was being dismissed,” she recalled with emotion. “I oftentimes felt like it was my fault that I had fibroids. That I was wasting people’s time because I was trying to figure out what I was going to do, and not have a hysterectomy, and that was the only answer I was getting.”

After searching and getting nowhere, Carmen finally learned about uterine fibroid embolization (UFE) from an acquaintance who also suffered from fibroids. After attending a free UFE hospital seminar presented by Dr. John Lipman, a vascular and interventional radiologist and fibroid specialist at Atlanta Interventional Institute, she was intrigued.

Uterine Fibroid Embolization - Using embolics to treat uterine fibroidsDuring the UFE procedure, a catheter is carefully inserted into an artery in the wrist or groin area and guided to the uterine arteries that supply fibroids with blood. Tiny particles are injected to cut off blood flow to the fibroids, causing them to shrink. The treatment is generally performed as an outpatient procedure and completed within about one hour.

Upon meeting with Dr. Lipman and learning of UFE, Carmen felt at ease. “He made sure that I had all the information and that I was well-informed, so I could make a logical decision.”

Carmen decided to get UFE and felt it was the best decision. “My pain [during recovery] was nothing compared to the menstrual cramps that I experienced every month,” she described. After resting for four days, she returned to work just one week after the procedure.

Fibroid Awareness Month - July - Image of women who may suffer from uterine fibroidsCarmen’s persistence paid off, and she avoided an unnecessary hysterectomy. “I’m hoping that I can use this platform to let other women know about UFE,” she emphasized. “Women who are afraid to wear white pants and who feel a gush of blood flowing every time they get up from their seat. Who pray they have not messed up their seat at work or messed up the back of their pants or their nice skirt when they go out to dinner or they go to church. I hope that by doing this, I let other women know—just like I found out—that there is an alternative.”

Hear from more patients who have overcome fibroids with UFE and now live full, healthy lives.


The above information should not be construed as providing specific medical advice but rather to offer readers information to better understand their lives and health. It is not intended to provide an alternative to professional treatment or to replace the services of a physician.


REFERENCES

  1. U.S. Food & Drug Administration. “Knowledge and News on Women: Fibroid Awareness Month”. July 1, 2021. https://www.fda.gov/consumers/knowledge-and-news-women-owh-blog/knowledge-news-women-fibroid-awareness-month
  2. U.S. Department of Health and Human Services. Office of Women’s Health. “Uterine Fibroids”. February 19, 2021. https://www.womenshealth.gov/a-z-topics/uterine-fibroids

What To Expect from Merit at SIR 2022 – “Advanced Outcomes Made Simple”

Advanced Outcomes Made Simple - SIR 2022Merit will be exhibiting at SIR 2022, the Society of Interventional Radiology’s Annual Scientific Meeting. Join us June 12 – 14 in Boston, MA, for a high-quality educational program with an international audience, in-person training, and hands-on workshops. Along with showcasing an exciting lineup of leading-edge products, this year we’re hosting a Lunch & Learn session you won’t want to miss.

Here’s a sneak peek of what you can expect at booth #418:

LUNCH & LEARN

Lunch is on us! We hope to see you Monday, June 13 at 12:00 PM EDT for the following educational presentation:

Case-Based Discussion of Steerable Technology in Treatment of VCF and Spinal Metastatic Disease

DATE: Monday, June 13

TIME: 12:00 pm EDT

WHERE: Booth #418

LEARNING OBJECTIVES:

  • Understand Clinical & Procedural Value of Steerable Devices
  • Discover Therapy-Awareness Strategies
  • Engage in Case-Based Discussion and Q&A

FACULTY

J. Dana Dunleavy - Think Spine Proctor

Dana Dunleavy, M.D.
Windsong Radiology Director of Interventional & Vascular Services
Buffalo, NY
Learn more about Dr. Dunleavy

PRODUCT SHOWCASE AT BOOTH #418

NEW Prelude Roadster™ Guide Sheath

Prelude Roadster

Expand your diagnostic and interventional procedures with the new Prelude Roadster, a longer guide sheath designed to access difficult anatomy in the peripheral vasculature. Stop by booth #418 to be among the first to discover this brand-new technology.

ReSolve® Thoracostomy Tray

ReSolve Thoracostomy Tray - Merit Medical

The ReSolve Thoracostomy Tray allows air (pneumothorax) and fluid (pleural effusion) to be drained from the pleural space through a percutaneous approach rather than an open surgical approach, providing your patients with minimally invasive care.

TEMNO Elite™ Biopsy System

Sample Assist - Biopsy Samples with the Push of a Button - TEMNO Elite Biopsy System - Merit Medical

The TEMNO Elite Biopsy System offers the reliability you expect with new features designed to provide superior soft tissue samples and total procedure control.

SplashWire™ Hydrophilic Steerable Guide Wire

SplashWire - REIMAGINE YOUR GUIDE WIRE

The Merit SplashWire combines optimum lubricity, exceptional torque response, and enhanced visibility, helping you achieve the successful outcomes you expect for your patients. We designed the SplashWire to successfully perform in the most complex cases.

ReSolve ConvertX® Nephroureteral & Biliary Stent System

ReSolve ConvertX - Ureteral or Biliary Obstructions

Drain to stent in 30 seconds1 with the ConvertX. Designed to treat ureteral and biliary obstructions, you can place it like any internal-external drain, then convert it to a stent when you’re ready.

Surfacer® Inside-Out® Access Catheter System

Surfacer® Inside-Out Access system - Restore Access, Preserve Options - Merit Medical

Pioneered by interventional cardiologist John Gurley, M.D., the Inside-Out approach was developed in response to patients with chronically occluded veins that required life-saving vascular access. Inserted in the femoral vein, the Surfacer Inside-Out Access Catheter System locates an exit from the right internal jugular vein, maintaining viable secondary veins if necessary.

See the Surfacer featured on the cover of June 2022 Journal of Vascular Surgery.

One-Vac™ Evacuated Drainage Bottle

One-Vac Evacuated Drainage Bottle

Engineered with an advanced design, the One-Vac is the smart option when choosing an evacuated drainage bottle. Built with a number of key features, the One-Vac makes percutaneous fluid collection and discard simple, efficient, and safe for you and your patients.

EmboCube® Embolization Gelatin

EmboCube Embolization Gelatin

Specifically designed for embolization of hypervascular tumors and blood vessels to occlude blood flow, EmboCube controls hemorrhaging in the peripheral vasculature. Gelatin is cut uniformly in preloaded 1-mL or 3-mL Medallion® Syringes to help ensure seamless prep and accurate delivery.

Embosphere® Microspheres

The most clinically studied spherical embolic, Embosphere is the clear choice among interventional radiologists. Designed for predictable and durable occlusion for the embolization of symptomatic uterine fibroids, AVMs, and hypervascular tumors, the elastic material allows for temporary compression of up to 33%3, yielding targeted results for patients and practitioners.

Merit Maestro® Microcatheters

Maestro Microcatheter - Embolotherapy Delivery System

A multipurpose microcatheter, the Maestro is designed to deploy coils up to 0.018″ and embolics up to and including 900 µm. A swan neck design helps you seat the catheter in the vessel, reducing the recoiling effect.

SwiftNINJA® Steerable Microcatheter

SwiftNINJAfull_coiled-sm

The SwiftNINJA is an innovative straight-tip catheter featuring an ergonomic steering dial that navigates up to 180 degrees and enables in vivo control. Consisting of a hydrophilic-coated distal 80 cm, the device delivers exceptional precision and speed even when you’re navigating the most challenging vascular ostium.

Prelude IDeal™ Hydrophilic Sheath Introducer

Prelude IDeal Sheath Introducer - Merit Medical

A hydrophilic access sheath with increased kink and compression resistance makes the IDeal the tool of choice for your radial access procedures.

Arcadia™ Steerable Balloon-Assisted Vertebral Augmentation

Arcadia Steerable Balloon-Assisted Vertebral Augmentation

The Arcadia is designed to achieve controlled, precise, targeted cavity creation in your vertebral augmentation procedures—whether your approach is unipedicular or bipedicular.

NEW AT MERIT: Arcadia™ Curved Delivery Cannula

Arcadia Curved Delivery Cannula - VCF

Stop by booth #418 and ask us about our NEW Arcadia™ Curved Delivery Cannula—a bone cement delivery system designed for predicable cement deposition across the midline of the vertebral body, optimizing cement volume, while potentially reducing the need for bipedicular access.

STAR™ Tumor Ablation System

STAR Tumor Ablation - Radiofrequency Ablation - Merit Medical

STAR delivers meaningful pain relief and localized tumor destruction in a single treatment. Your patients will appreciate that this mechanism is designed to perform successfully and comfortably in an outpatient setting.


We look forward to seeing you at SIR 2022 and discussing all the ways we can help you enhance your patient care. Questions? Contact our Customer Support team and speak to one of our representatives. Live chat, phone, or email—we are here for you.

Don’t forget to follow us on social media for live conference updates!


Before using any of the Merit products mentioned above, refer to Instructions for Use for indications, contraindications, warnings, precautions, and directions for use.

REFERENCES

  1. Data on File.
  2. Laurent et al. Am J Neuroradial 1996.

Men’s Health Month: Reclaiming Quality of Life with Prostatic Artery Embolization

Merit Medical Brings Awareness to Men's HealthJune is Men’s Health Month, a time we use at Merit to raise awareness about conditions that affect men, encouraging individuals to take control of their health and live their best lives. We do this by providing the products and education needed to help physicians and patients learn more about life-changing procedures. One such procedure called prostatic artery embolization (PAE) is a minimally invasive approach to treating bothersome urinary symptoms caused by an enlarged prostate, also known as benign prostatic hyperplasia (BPH).

We sat down with Larry Sago, a patient who underwent PAE, to hear his story and better understand how life changing the procedure can be.

“The difference is like night and day,” Larry said, describing his life before and after prostatic artery embolization (PAE).

Larry’s journey began when he was diagnosed with BPH. A common condition, about half of all men in their 50s develop BPH—a statistic that increases with age.1 Although non-cancerous, BPH can cause a host of bothersome urinary symptoms, including feelings of urinary urgency, weak or interrupted urine stream, and urinary frequency.

Larry Sago - Mens Health Month - PAEFor months prior to undergoing PAE, BPH began to take a major toll on Larry’s life. He started experiencing urine retention and found at times he couldn’t go at all. In pain, Larry resorted to driving himself to the ER to get a Foley catheter inserted to temporarily relieve the pressure.

For many men like Larry who suffer from BPH, the first line of treatment is commonly prescription medications to treat the symptoms, but these are occasionally ineffective and often have less-than-desirable side effects. After trying medications, Larry found his symptoms couldn’t be controlled any longer and continued to worsen. “My urologist told me TURP [transurethral resection of the prostate] was about the only answer.”

TURP is a surgical procedure that cuts away the prostate tissue that blocks the flow of urine. While very effective in improving urination, it can be associated with complications like bleeding, urinary leakage, and sexual side effects. The bleeding risks become more concerning the larger the prostate becomes.

Not wanting to have surgery or to risk having the complications associated with TURP, Larry researched non-surgical treatment options online but wasn’t finding much. As luck would have it, Larry one day found an article by University of North Carolina (UNC) Clinical Assistant Professor of Radiology Dr. Ari Isaacson discussing minimally invasive PAE at the UNC Health Care System’s Center for Heart and Vascular Care.

“I emailed Dr. Isaacson as soon as I read about [PAE],” Larry recalled. “Amazingly, within half an hour he’d written me back asking for my phone number to further talk about the procedure. He called me and communicated all aspects of [PAE] very clearly.” Liking what he heard, Larry drove from Atlanta to Chapel Hill to meet with Dr. Isaacson. Once a biopsy cleared him of prostate cancer, Larry was able to undergo the procedure as part of a clinical trial.

PAE is performed by an interventional radiologist and takes approximately one to two hours to complete. Under conscious sedation, a small puncture is made in the upper thigh or arm. A slender catheter is then inserted and guided via real-time imaging into the prostatic arteries that supply the prostate with blood. Tiny embolic particles are injected into these arteries, blocking blood flow to the enlarged areas of the prostate. Once deprived of blood, these areas of tissue die (necrosis).

“PAE results in shrinking and softening of the prostate which allows for urine to flow through easier, ultimately reducing urinary symptoms,” Dr. Isaacson explained. “Some of the advantages of PAE are that it is performed as an outpatient procedure, and the recovery time is quick. In most cases, no Foley catheter is required. PAE also has very little chance of affecting sexual function. In some cases, sexual function is even improved after patients are able to stop taking BPH medications.”

Post-PAE, Larry describes the procedure as easy with no pain or bleeding. Afterward, he was able to go back to his hotel room in Chapel Hill, spend the night, and drive home to Atlanta the next day. “For about a week, my former BPH symptoms returned, but they were briefer and milder this time. Once they went away, I felt like I was 20 years old again!”

PAE not only resulted in clinical improvements, it also gave Larry something priceless—his life back.

“I literally don’t think about the symptoms I used to struggle with,” Larry said. “I can go play golf without having to worry about going to the bathroom in the middle of the golf course!”

Ari Isaacson - Mens Health Month - PAE“I’m so pleased for Larry,” Dr. Isaacson noted. “His case demonstrates how effective this procedure can be. Many PAE patients can enjoy improved urination for years following the procedure.”

Feeling truly fortunate to have been a candidate for PAE, Larry said the only thing he would’ve done differently was have the procedure sooner. “If this treatment had been available, I would’ve done it years earlier. I simply hope there’s more awareness so that others can experience the boost in quality of life and long-term health that I did.”

Explore other patient testimonials and learn more about PAE.

At Merit, our mission is to improve the lives of people, families, and communities around the globe. If Larry’s story resonated with you, and you’re experiencing bothersome symptoms from BPH, talk to your doctor today to see if PAE might be an option for you.


The above information should not be construed as providing specific medical advice but rather to offer readers information to better understand their lives and health. It is not intended to provide an alternative to professional treatment or to replace the services of a physician.

REFERENCES

  1. Urology Care Foundation. (n.d.). What Is Benign Prostatic Hyperplasia (BPH)? Retrieved from http://www.urologyhealth.org/urologic-conditions/benign-prostatic-hyperplasia-(bph)/

Join Merit Medical for Hands-on Workshops at the European Vascular Course 2022

European Vascular Course 2022 - Hands On WorkshopsMerit will be exhibiting at the European Vascular Course, held from 12 – 14 June in Maastricht. The course will celebrate its 25th anniversary and will comprise more than 300 workshops. Our team will be showcasing cutting-edge technologies and hosting seven experiential hands-on workshops. Please register for our workshop program via www.vascular-course.com. We look forward to seeing you in person at booth #28 and training room #2.4!

Check out what the Merit team has in store for attendees:

PHYSICIAN EDUCATION

Serious Challenges in the Dialysis Access Circuit: What Treatment Options Would You Choose and Why?

Course Option 1:

  • DATE: Sunday, 12 June
  • TIME: 16:30 – 18:00 CEST

Course Option 2:

  • DATE: Tuesday, 14 June
  • TIME: 09:00 – 10:30 CEST

Faculty:

  • Mr. James Gilbert, Transplant & Vascular Access Surgeon, Oxford, UK

Learning Objectives:

  • Understand development in dialysis access
  • Provide options in complex, unusual, and desperate access situations
  • Learn treatment and patient algorithm
  • Increase knowledge and skill set on the use of the Merit WRAPSODY™ Cell-Impermeable Endoprosthesis, HeRO® Graft, and Surfacer® Inside-Out® procedures

Attendees: This training session is designed for physicians with an interest in difficult ESRD access with patients who have central venous stenosis and central venous occlusion: vascular surgeons, interventional radiologists, and nephrologists.

Merit WRAPSODY Cell-Impermeable Endoprosthesis

Maintain Long-Term Vessel Patency - Merit WRAPSODY

HeRO Graft

HeRO Graft - Hemodialysis Reliable Outflow

Surfacer Inside-Out Access Catheter System


How Low Can You Go? Benefits of Treating to the Lowest Point of Incompetence.

Course Option 1:

  • DATE: Sunday, 12 June
  • TIME: 10:00 – 11:00 CEST

Course Option 2:

  • DATE: Monday, 13 June
  • TIME: 16:00 – 17:00 CEST

Faculty:

  • Mr. Leith Williams, Vascular Surgeon, Wirral, UK

Learning Objectives:

  • Understand the benefits of treating advanced venous disease with non-thermal, non-tumescent (NTNT) technique
  • Learn an innovative approach to treat VLU
  • Experience a practical approach to the ClariVein® OC device and the procedure

Attendees: This training session is designed for physicians with an interest in chronic venous insufficiency and phlebology: vascular surgeons, interventional radiologists, phlebologists, angiologists, dermatologists, and physician associates.

ClariVein OC - treatment for endovenous mechanochemical ablation

Tackle Common Procedural Challenges: Wires, Catheters, and Snares—Which Are the Best Options?

Course:

  • DATE: Sunday, 12 June
  • TIME: 13:00 – 14:30 CEST

Faculty:

  • The Merit Education Team

Learning Objectives:

  • Learn the basics of diagnostic wires, catheters, and snares
  • Understand how to differentiate between Teflon wires and hydrophilic wires
  • Explore how to cannulate visceral and cerebral vessels by using different wires and catheters as well as the removal of foreign objects

Attendees: This training session is designed for residents with an interest in interventional radiology.


Distal First? What’s New in Transradial Access.

Course:

  • DATE: Monday, 13 June
  • TIME: 12:00 – 13:30 CEST

Faculty:

  • The Merit Education Team

Learning Objectives:

  • Understand proximal and distal radial access as well as how it impacts practices
  • Learn ultrasound access techniques with POV instruction, haemostasis, and avoid common pitfalls
  • Comprehend case selection and patient prep workflow

Attendees: This training session is designed for physicians with an interest in radial and distal radial access: interventional cardiologists, interventional radiologists, neurointerventional radiologists, and interventional nephrologists.


Vascular Access Nurse—What Is the Latest ESRD Access That Can Benefit Patients with Failing Fistulas and Grafts?

Course:

  • DATE: Monday, 13 June
  • TIME: 09:20 – 11:00 CEST

Faculty:

  • The Merit Education Team

Learning Objectives:

  • Understand development in dialysis access
  • Support vascular wellness best practice
  • Improve vascular access care for patients

Attendees: This training session is designed for nurses with an interest in difficult ESRD access with patients who have central venous stenosis and central venous occlusion.

PRODUCT SHOWCASE AT BOOTH 28

Hero Graft front cutaway diagram of graft insertion into patientHeRO® Graft

The HeRO Graft, a hemodialysis access graft designed for catheter-dependent patients or those failing fistulas or other grafts, offers a 69% reduction in future infections compared to patients receiving catheters as well as a cost-saving of 23% on average per year.

Surfacer® Inside-Out Access system - Restore Access, Preserve Options - Merit MedicalSurfacer® Inside-Out® Access Catheter System

Pioneered by interventional cardiologist John Gurley, M.D., the Inside-Out approach was developed in response to patients with chronically occluded veins that required life-saving vascular access. Inserted in the femoral vein, the Surfacer® Inside-Out® Access Catheter System locates an exit from the right internal jugular vein, maintaining viable secondary veins if necessary.

See the Surfacer featured on the cover of June 2022 Journal of Vascular Surgery.

Maintain Long-Term Vessel Patency - Merit WRAPSODYMerit WRAPSODY™ Cell-Impermeable Endoprosthesis

Featuring a unique tri-layered endoprosthesis microstructure, the Merit WRAPSODY Cell-Impermeable Endoprosthesis extends long-term vessel patency in patients who experience obstructions in the dialysis outflow circuit. The hydrophilic coating allows pinpoint accuracy, smooth insertion, and withdrawal with top-tier trackability.

Please Note: The Merit WRAPSODY Cell-Impermeable Endoprosthesis is not available for sale or use within the United States.

ClariVein OC Infusion CatheterClariVein® OC Infusion Catheter

A minimally invasive solution for patients, the ClariVein® OC Infusion Catheter features a unique 360-degree rotatable dispersion wire at the distal end. The catheter design has been engineered with a small profile, exceptional flexibility, strong imaging visualization, and excellent pushability.

Please Note: The ClariVein OC Infusion Catheter is not available for sale or use within the United States.

Mini Access Kits - Merit MAKMerit MAK™ Mini Access Kit

To access the vascular system, Merit MAK Mini Access Kits take a very small approach, minimizing bleeding and trauma for the patient. Merit MAK guide wires are carefully engineered with a fully enclosed hoop and available in several configurations. Each kit includes a coaxial introducer/dilator pair, 21G needle, and guide wire.


Merit is committed to offering healthcare professionals the technologies and education opportunities they need to improve patient care. We are proud to participate in EVC 2022 and look forward to seeing you in person. Register for EVC and all workshops at www.vascular-course.com.

Merit WRAPSODY™ Endoprosthesis and ClariVein® OC are not approved or available for sale in the United States.

Before using any of the Merit products mentioned above, refer to Instructions for Use for indications, contraindications, warnings, precautions, and directions for use.

REFERENCES

  1. Katzman et al., J Vasc Surg 2009.
  2. Dageforde et al., JSR 2012.

Join Merit Medical for Educational Sessions and Live Case Transmission at LINC 2022

LINC 2022 - Join Merit at Booth 39We look forward to attending the Leipzig Interventional Course (LINC), held from 6 to 9 June, in person and online. Our team will be hosting a satellite symposium with live case transmission and several on-demand learning centre sessions. Attendees can also visit Merit booth #39 to explore multiple product innovations.

Mark your calendars—here’s an outline of what we have planned:

SATELLITE SYMPOSIUM

DATE: Monday, 6 June

TIME: 15:50 – 17:05 CEST

WHERE: Main Arena 2 & Online

LEARNING OBJECTIVES

  • Follow an overview on the evolution of covered stents
  • Learn more about the current WRAPSODY trial pipeline (FIRST, IDE, and Registry)
  • Understand how to manage patients and how to decide their best treatment options (i.e., treatment algorithm)
  • Discover how the WRAPSODY can be beneficial and cost effective in daily treatment

AGENDA

TIMEDESCRIPTIONFACULTY
15:50 – 15:53Introduction by the moderatorProf. Dr. Fabrizio Fanelli
15:53 – 16:04The evolution of covered stentsDr. Tobias Steinke
16:04 – 16:16Live case transmission from Varese University of InsubriaProf. Dr. Matteo Tozzi
16:16 – 16:27Clinical trials: WRAPSODY FIRST, IDE, and RegistryProf. Dr. Dheeraj Rajan
16:27 – 16:39Recorded case presentationDr. Tobias Steinke
16:39 – 16:50The algorithm for covered stent treatmentDr. Ounali Jaffer
16:50 – 17:00Health economics in covered stent management: An overviewProf. Katarzyna Kolasa
17:00 – 17:05Final Q&A and wrap-up

LEARNING CENTRE SESSIONS

CENTRE 1

Rethinking AVF Management: WRAPSODY, the Cell-Impermeable Endoprosthesis in Challenging AV Access Repair

Faculty:

  • Dr. Tobias Steinke, Vascular Surgeon, Schön Klinik, Dusseldorf, Germany
  • Dr. Andrew Wigham, Interventional Radiologist, Churchill Hospital, Oxford, United Kingdom
Maintain Long-Term Vessel Patency - Merit WRAPSODY

CENTRE 2

Transradial TACE with HepaSphere™ Microspheres: A Journey from Patient Selection to Outcome

Faculty:

  • Dr. Darren Klass, Clinical Associate Professor, University of British Columbia, Vancouver, Canada; Consultant Radiologist, Cleveland Clinic, London, United Kingdom

CENTRE 3

ClariVein® OC Procedural Video

Faculty:

  • Mr. Leith Williams, Vascular Surgeon, Wirral, United Kingdom
ClariVein OC - treatment for endovenous mechanochemical ablation

PRODUCT SHOWCASE IN BOOTH 39

Hero Graft front cutaway diagram of graft insertion into patientHeRO® Graft

The HeRO Graft, a hemodialysis access graft designed for catheter-dependent patients or those failing fistulas or other grafts, offers a 69% reduction in future infections compared to patients receiving catheters as well as a cost-saving of 23% on average per year.

Surfacer® Inside-Out Access system - Restore Access, Preserve Options - Merit MedicalSurfacer® Inside-Out® Access Catheter System

Pioneered by interventional cardiologist John Gurley, M.D., the Inside-Out approach was developed in response to patients with chronically occluded veins that required life-saving vascular access. Inserted in the femoral vein, the Surfacer® Inside-Out® Access Catheter System locates an exit from the right internal jugular vein, maintaining viable secondary veins if necessary.

See the Surfacer featured on the cover of June 2022 Journal of Vascular Surgery.

Maintain Long-Term Vessel Patency - Merit WRAPSODYMerit WRAPSODY™ Cell-Impermeable Endoprosthesis

Featuring a unique tri-layered endoprosthesis microstructure, the Merit WRAPSODY Cell-Impermeable Endoprosthesis extends long-term vessel patency in patients who experience obstructions in the dialysis outflow circuit. The hydrophilic coating allows pinpoint accuracy, smooth insertion, and withdrawal with top-tier trackability.

Please Note: The Merit WRAPSODY Cell-Impermeable Endoprosthesis is not available for sale or use within the United States.

ClariVein OC Infusion CatheterClariVein® OC Infusion Catheter

A minimally invasive solution for patients, the ClariVein® OC Infusion Catheter features a unique 360-degree rotatable dispersion wire at the distal end. The catheter design has been engineered with a small profile, exceptional flexibility, strong imaging visualization, and excellent pushability.

Please Note: The ClariVein OC Infusion Catheter is not available for sale or use within the United States.

Mini Access Kits - Merit MAKMerit MAK™ Mini Access Kit

To access the vascular system, Merit MAK Mini Access Kits take a very small approach, minimizing bleeding and trauma for the patient. Merit MAK guide wires are carefully engineered with a fully enclosed hoop and available in several configurations. Each kit includes a coaxial introducer/dilator pair, 21G needle, and guide wire.

Embosphere MicrospheresEmbosphere® Microspheres

The most clinically studied spherical embolic, Embosphere is the clear choice among interventional radiologists. Designed for predictable and durable occlusion for the embolisation of symptomatic uterine fibroids, ABMs, and hypervascular tumours, the elastic material allows for temporary compression of up to 33%,3 yielding targeted results for patients and practitioners.

EmboCube® Embolization GelatinEmboCube® Embolization Gelatin

Specifically designed for embolisation of hypervascular tumours and blood vessels to occlude blood flow, EmboCube consistently controls haemorrhaging in the peripheral vasculature. Gelatin is cut uniformly in preloaded 1-mL or 3-mL Medallion® Syringes to help ensure seamless prep and accurate delivery.

SwiftNINJA® Steerable MicrocatheterSwiftNINJA® Steerable Microcatheter

The SwiftNINJA is an innovative straight-tip catheter featuring an ergonomic steering dial that navigates up to 180 degrees and enables in vivo control. Consisting of a hydrophilic-coated distal 80 cm, the device delivers exceptional precision and speed navigating even in the most challenging vascular ostium.


We look forward to seeing you at LINC 2022 and presenting all the ways we can partner with you for better patient care. Questions? Contact our Customer Support team and speak to one of our representatives via live chat, phone, or email.

Merit WRAPSODY™ Endoprosthesis and ClariVein® OC are not approved or available for sale in the United States.

Before using any of the Merit products mentioned above, refer to Instructions for Use for indications, contraindications, warnings, precautions, and directions for use.

REFERENCES

  1. Katzman et al., J Vasc Surg 2009.
  2. Dageforde et al., JSR 2012.
  3. Laurent et al. Am J Neuroradial 1996.

Join Merit Medical for “The Flow Stops Here” at GEST 2022

The Flow Stops Here - GEST 2022Merit will be exhibiting at GEST 2022: Global Embolization Oncology Symposium Technologies. This year’s annual conference features an international audience with in-person training and hands-on workshops in New York, NY. Our theme for this year’s Symposium is The Flow Stops Here, a bold commitment to offering high-quality embolotherapy products and services designed to improve outcomes for physicians and their patients.

PRODUCT SHOWCASE AT BOOTH #801

Embosphere MicrospheresEmbosphere® Microspheres

The most clinically studied spherical embolic, Merit’s Embosphere Microspheres are the clear choice among interventional radiologists. Designed for predictable and durable occlusion for the embolization of symptomatic uterine fibroids, ABMs, and hypervascular tumors, the elastic material allows for temporary compression of up to 33%,1 yielding targeted results for patients and practitioners.

Embocube Embolization GelatinEmbocube® Embolization Gelatin

Specifically designed for embolization of hypervascular tumors and blood vessels to occlude blood flow, Embocube Embolization Gelatin consistently controls hemorrhaging in the peripheral vasculature. Gelatin is cut uniformly in preloaded 1-mL or 3-mL Medallion® Syringes to help ensure seamless prep and accurate delivery.

SwiftNINJASwiftNINJA® Steerable Microcatheter

The SwiftNINJA Steerable Microcatheter is an innovative straight-tip catheter featuring an ergonomic steering dial that navigates up to 180 degrees and enables in vivo control. Consisting of a hydrophilic-coated distal 80 cm, the device delivers exceptional precision and speed navigating even in the most challenging vascular ostium.


We look forward to seeing you at GEST 2022—where #TheFlowStopsHere!

Questions? Contact our Customer Support Center, and speak to one of our representatives via live chat, phone, or email.

Before using any of the Merit products mentioned above, refer to Instructions for Use for indications, contraindications, warnings, precautions, and directions for use.

REFERENCES

  1. Laurent et al. 1996. “Trisacryl Gelatin Microspheres for Therapeutic Embolization, I: Development and In Vitro Evaluation.” Am J Neuroradial 17:533-540

“A Real Winning Combination”: Prelude IDeal™ and PreludeSYNC DISTAL™ Provide Complete Solution for Distal Radial Access

Distal Radial AccessDistal radial access has emerged as an accessible, optimal solution for physicians seeking to provide the greatest experience for their patients. While femoral and traditional radial access have previously been standard, distal radial offers additional advantages to both patient and operator. To support distal radial artery access, Merit offers a suite of products designed to minimize risk, maximize patient comfort, and provide ease of use for care teams to incorporate.

Ethan C. Korngold, MD, FSCAI - Distal Radial AccessWe spoke with Ethan C. Korngold, MD, FSCAI, interventional cardiologist at Providence St. Vincent Hospital in Portland, OR, to hear his experience choosing two Merit products in particular for his distal radial artery access procedures: the Prelude IDeal Hydrophilic Sheath Introducer and the PreludeSYNC DISTAL, a radial compression device specially created for the distal radial access site.

Why Distal Radial?

Literature shows that radial access provides multiple benefits, including less bleeding complications, decreased procedure cost, and enhanced sheath performance.1

According to Dr. Korngold, patients undergoing distal radial access interventions may experience additional advantages over radial access, including increased mobility post-procedure. “It is much less invasive than traditional radial access—my patients are able to resume normal activities much more quickly,” Dr. Korngold says. “Distal radial access may also lead to less occlusion of the radial artery. I think the important thing is that it preserves the radial artery should future interventions be necessary.”

Mitigating Risk

Prelude IDeal Sheath Introducer - Merit MedicalKinking and compressing are recognized challenges for operators when navigating catheters during radial access procedures.

“It’s very important when performing distal access to have a sheath that’s kink resistant. I really do prefer the kink resistance of the braided Prelude IDeal sheath. I also find it has impressive push forces; it’s a stronger, stiffer sheath that performs better than others I’ve used,” Dr. Korngold explains.

Merit designed the Prelude IDeal specifically to reduce the impact of these risks to patients. Composite braiding technology gives the Prelude IDeal sheath a 13% thinner wall than the leading competitor.2 With proprietary engineering, the sheath is thinner and stronger while achieving 124% increased compression resistance and 23% more kink resistance than the leading competitor.2

Prelude IDeal Compression & Kink Resistance Features

Dr. Korngold shares his firsthand experience with similar products. “I’ve used other non-braided sheaths, both slender and non-slender varieties. I found that even the non-slender varieties are just too prone to kinking. The kink resistance of the Prelude IDeal is excellent; it’s an essential feature for distal radial access.”

Maximizing Patient Comfort

PreludeSYNC DISTAL - Secure, Comfortable and EffectiveDr. Korngold has found that he’s received significantly fewer patient complaints of swelling, discomfort, or hematomas since opting for the PreludeSYNC DISTAL.

Constructed with soft material, the PreludeSYNC DISTAL provides comfortable wear. Its three-strap band configuration allows for an adjustable fit with optional extension if needed especially for larger hands. The PreludeSYNC DISTAL also delivers clear, unobstructed site visibility for focused compression. A built-in Slip-n-Lock™ Cap provides a specialized connection, securing syringes during inflation and deflation, supporting patient safety.

“The PreludeSYNC DISTAL band is really just perfectly designed. Everyone who does distal radial access has experimented with different ways of doing it. No solution is as efficient, convenient, or as comfortable for patients,” Dr. Korngold says.

Ease of Use

Medical devices must be effective, but equally important is ease of use. Dr. Korngold reports that incorporating the Prelude IDeal and PreludeSYNC DISTAL into his practice was seamless.

“It’s very easy to train the care team on how to use them properly,” he says, referring to his experience introducing both products to his staff. “Our nurses on the floor found it very intuitive and easy to manage. Both products fit perfectly into our existing workflows, so I’d say it’s a real winning combination.”

A Complete Solution

Merit is committed to developing tools that improve patient’s lives in partnership with the physicians who provide their care. The Prelude IDeal Hydrophilic Sheath Introducer and PreludeSYNC DISTAL are prime examples of this dedication and have become the go-to tools for distal radial access procedures around the globe.

Discover the Prelude IDeal Hydrophilic Sheath Introducer and the PreludeSYNC DISTAL, and live chat with our Customer Support team to see how you can incorporate them into your practice.


REFERENCES

  1. Rathore S et al. 2010. “Impact of Length and Hydrophilic Coating of the Introducer Sheath on Radial Artery Spasm During Transradial Coronary Intervention.” JACC 3, no. 5 (May): 475 ̶ 483. PMID: 20488402.
  2. 6F Data on File.

Merit Medical Recognizes National Kidney Month

Merit Recognizes National Kidney MonthMarch is National Kidney Month, and Merit Medical is committed to empowering the health and wellness of people living with chronic kidney disease and their caregivers. At Merit, our goal is to support the renal health community through a vast array of state-of-the-art therapeutic products, physician education courses, and patient education tools that equip clinicians to make a difference for people living with chronic kidney disease.

According to the National Institutes of Health, approximately 37 million Americans live with chronic kidney disease.1 Although incidences of chronic kidney disease have risen consistently, 9 out of 10 people are not aware of their diagnosis because early-stage kidney disease generally has no symptoms.1

The U.S. Renal Data System 2020 Annual Report cited that approximately 786,000 Americans live with end-stage renal or kidney disease, with 71% (558,000) of those receiving dialysis and 29% (228,000) receiving a kidney transplant.2 People living with end-stage kidney disease require dialysis therapy to regulate body functions, including controlling blood pressure, because their kidneys no longer can.3 Without access to adequate, regular, and affordable dialysis care, people living with end-stage kidney disease will not survive.3

As the number of people impacted by kidney disease continues to increase, Merit’s significant commitment to the renal health community is crucial. Merit is uniquely positioned with hemodialysis and peritoneal dialysis (PD) options for treatments and ancillary products that make a difference for dialysis patients who depend on high-quality care.


Merit Products

HeRO Graft - Hemodialysis Reliable Outflow

Super HeRO®

The Super HeRO Adapter and Support Seal system equips surgeons with standard wall and early cannulation vascular graft options. In addition to reducing hospital admissions due to catheter infections, the Super HeRO helps hospitals and dialysis centers save $3,100 per patient per year when converting catheter-dependent patients to the HeRO graft.

HeRO Graft - Hemodialysis Reliable Outflow

HeRO Graft®

For catheter-dependent patients, or those whose kidney function fails to improve with fistulas or grafts, Merit has engineered a solution: the HeRO Graft, a hemodialysis access graft designed precisely for these patients. Research indicated a 69% reduction in future infections with the HeRO Graft compared to patients receiving catheters.

Surfacer Now Available In the United States - Merit Medical

Surfacer® Inside-Out® Access Catheter System

The Inside-Out approach was developed by John Gurley, M.D., in response to patients with chronically occluded veins. The Surfacer Inside-Out Access Catheter System is inserted through the femoral vein and navigated to an exit point in the right internal jugular vein, preserving the viability of secondary central veins.

Home Dialysis Continues to Be a Nationwide Interest

Peritoneal Dialysis Catheters

To improve flow rates by 30%, Merit designed Flex-Neck Peritoneal Dialysis Catheters with an internal diameter (ID) that is 35% larger than competitors. Infant catheters come in one and two cuff configurations, and each catheter kit has a unique stenciling system for improved placement accuracy.

Centros® & CentrosFLO® Hemodialysis Catheters

CentrosFlo® Hemodialysis Catheters

Featuring self-centering curved tips to promote optimal blood flow and minimize recirculation rates, The Centros (without side holes) and the CentrosFLO™ (with side holes) long-term hemodialysis catheters reach the pinnacle of overall catheter performance. Designed by Dr. Stephen Ash, Merit’s 15F catheters feature a large internal lumen, promoting a flow rate up to 450 mL/minutes.

ProGuide™ Chronic Dialysis Catheters

ProGuide™ Chronic Dialysis Catheters

Designed for patient comfort, ease of insertion, and maintenance, ProGuide Chronic Dialysis Catheters are inserted through a valved peel-away sheath or over-the-wire placements and available in catheter lengths from 19 cm to 50 cm (tip to cuff). Available configurations include standalone catheter, basic kit, complete kit, and complete kit with mini access kit.


Physicians and surgeons look to Merit to provide insightful resources and cutting-edge therapeutic products designed to make a difference for people living with chronic kidney disease. Merit designs and innovates leading products specifically for patients receiving dialysis. For more information on how you can incorporate our biopsy products into your practice, please contact Merit Customer Support.


REFERENCES

  1. National Institutes of Health. National Kidney Month 2022. Retrieved from https://www.niddk.nih.gov/health-information/community-health-outreach/national-kidney-month
  2. American Society of Nephrology. (April 2021). Dialysis Care Around The World: A Global Perspective. Retrieved from https://kidney360.asnjournals.org/content/2/4/604
  3. National Kidney Foundation. Dialysis Info. Retrieved from https://www.kidney.org/atoz/content/dialysisinfo

What’s Your Clinical Challenge? We Have a Solution.

As a leader in customer-focused healthcare, Merit Medical’s priority is to ensure that you have the tools you need to care for your patients. Ranging from product kits to education opportunities, our Complete Solutions simplify preparation and streamline procedures to support quality patient care with a trusted, innovative range of medical devices.


BIOPSY

Biopsy Solution

We offer a wide range of reliable biopsy devices for precise samples every time. Our proven soft tissue biopsy brands, such as Achieve®, Temno®, Tru-Cut®, and CorVocet®, offer a complete selection with advanced features to obtain top-quality tissue samples with ease and efficiency.

LEARN MORE >

CARDIAC CATHETERIZATION

Our cardiac catheterization solutions provide you with a variety of tools to help you accurately diagnose and successfully treat patients with heart problems. From sheath introducers, like our Prelude IDeal™, and guide wires to catheters, inflation devices, and more, we offer a number of superior devices for your procedures.

LEARN MORE >

CRITICAL CARE

Critical Care Solutions

When treating vulnerable patients, every product you use matters. We offer a broad spectrum of tools designed for patients being treated in the critical care unit. Merit critical care technologies aim to reduce contaminant exposure, accurately monitor patient blood pressure, and decrease workplace injury, helping you provide treatment that is safe, effective, and efficient.

LEARN MORE >

DIALYSIS ACCESS

Dialysis Access Solution

Kidney disease is a global issue, and access is the foundation for any successful dialysis procedure. Our comprehensive dialysis access portfolio, including our catheter-dependence reducing HeRO® Graft, brings reliable and innovative solutions to your practice.

LEARN MORE >

PERITONEAL DIALYSIS

Our home dialysis options offer several patient advantages over in-center dialysis, including better kidney disease-related quality of life. We offer virtual and hands-on physician training, a wide range of catheter sizes, accessories, kits, and patient resources.

LEARN MORE >

RADIAL

Radial access has many well-documented benefits that include improved patient safety, a significant reduction in cost of care, and increased patient and staff satisfaction. We support radial access with a diverse portfolio of innovative products and a world-renowned hands-on physician education program, helping you offer the advantages of radial to your patients.

LEARN MORE >

DISTAL RADIAL ACCESS

Distal radial artery access offers both patient and operator advantages. To help bring these benefits to your practice, we provide advanced training on the distal technique as well as innovative products to support your procedures, such as the first-to-market PreludeSYNC DISTAL™ Radial Compression Device.

LEARN MORE >

DRAINAGE

Over the past two decades, we have continually expanded our drainage portfolio to include a diverse range of solutions that work together to help you achieve optimal drainage care. We offer multiple drainage catheters designed to lessen trauma and promote a more accurate placement.

LEARN MORE >

ELECTROPHYSIOLOGY & CRM

Successful diagnosis and treatment of electrical cardiac activity is crucial—this is why we offer a range of physician education courses and specialized tools to assist in making accurate diagnoses and create effective treatment plans. Features include extra-stiff transseptal needles, ergonomic handles for exceptional control, and advanced introducer systems.

LEARN MORE >

EMBOLOTHERAPY

Our proprietary embolic products are the most studied on the market and allow for efficient and safe delivery and predictable outcomes. To complement our offerings, we provide excellent ongoing customer service to ensure you have the tools you need for your procedures.

PROSTATIC ARTERY EMBOLIZATION
To help support your prostatic artery embolization (PAE) practice, we offer virtual and hands-on training, trusted products, clinical resources, patient materials, and more.


UTERINE FIBROID EMBOLIZATION
Our uterine fibroid embolization (UFE) solutions offer trusted products that deliver predictable clinical results as well as long-term symptom control.


We also offer extensive patient resources at our Ask4PAE and Ask4UFE sites.

LEARN MORE >

GASTROENTEROLOGY STRICTURE MANAGEMENT

GI Stricture Management

Merit Endoscopy’s fully covered, laser-cut esophageal stent technology provides for accurate placement and minimized migration. In addition to our state-of-the-art stent technology, we deliver best-in-class dilation products, including our BIG60® Inflation Device and our Elation dilation balloons as well as enhanced physician training.

LEARN MORE >

PULMONARY STRICTURE MANAGEMENT

For patients with tracheobronchial strictures, stent technology can provide rapid palliation and improve quality of life. We offer fully covered, laser-cut tracheobronchial stents and advanced over-the-wire and direct visualization delivery systems. Download case studies and participate in virtual and hands-on training—all designed to help you advance patient care.

LEARN MORE >

KITS & PACKS

Designed to bring convenience and efficiency to your office, our kits and packs solutions can help simplify prep and procedure, support quality patient care, and reduce inventory levels. Our team analyzed hundreds of kits and created a set of standard configurations that meet the needs of the majority of cath labs, interventional radiology, and vascular surgery departments. We also offer customizable kits to fit your unique procedural needs.

LEARN MORE >

SPINE

Through a diverse portfolio of sophisticated steerable technologies, we deliver complete procedural solutions designed to treat pathologies of the vertebrae, reduce pain, and improve patient quality of life. Our comprehensive education programs and unique products allow physicians to address patient-specific needs and physician preference in the treatment of vertebral pathologies.

LEARN MORE >

VENOUS

Venous Solutions from Merit Medical

Our minimally invasive venous solutions are designed to treat symptoms, minimize post-operative pain, and provide faster recovery. Explore products, accessories, and kits, packs, and trays—each complementing the next to provide you with better patient outcomes.

LEARN MORE >


Merit’s dedication to comprehensive customer care starts with providing the tools you need to treat your patients. Ready to get started? Available via email, phone, and live chat, our Customer Support team is here to help find a solution for you. Browse our virtual in-service and product support videos, all designed to help you obtain additional product knowledge and insights. We look forward to working with you.

ReSolve ConvertX® and Treatment of Biliary Obstructions in Pancreatic Cancer: A Physician’s Experience

Simplifying Patient Treatment with ReSolve ConvertXPancreatic cancer is the 12th most common cancer worldwide. In the US alone, approximately 60,430 people will be diagnosed with pancreatic cancer this year. Biliary obstructions are a common condition associated with pancreatic cancer. Patients with biliary obstructions often experience discomfort, such as abdominal pain, weight loss, nausea and vomiting, jaundice, and fever. Left untreated, biliary obstructions can lead to serious complications, including infection.

To help treat this patient population, Merit Medical offers the ReSolve ConvertX Biliary Stent System, a unique technology designed for temporary internal drainage in individuals with severe biliary obstructions.

The below case study and physician discussion presents successful treatment of a biliary obstruction with the ReSolve ConvertX in a patient with terminal pancreatic cancer.

CASE STUDY

Patient Profile: Elderly patient with terminal pancreatic cancer. Malignant tumor growth led to obstructions in the right and left hepatic ducts. Traditional bilateral biliary drains were placed to relieve symptoms of jaundice, infections, and abdominal pain.

Complications: Patient experienced frequent accidental pulling on the external portion of the drainage systems and returned to the interventional radiology department for multiple reinterventions. Lesions developed due to bile leakage through the existing track and irritating the skin. Patient also expressed that the two external bags were burdensome.

Procedure: Both biliary drains were removed over an Amplatz-style wire and were replaced with the ReSolve ConvertX Biliary Stent System. After both ReSolve ConvertX drains were in place, they were each converted, leaving only the stent portions in place.

Outcomes/Results: After placement, patient was happy with the treatment and able to experience relief and an improvement in quality of life.

Sample flouro of ReSolve ConvertX Biliary Stent Placement
Sample flouro of ReSolve ConvertX Biliary Stent Placement

Listen in as Mark H. LeQuire, MD, FACR, Diagnostic, Vascular & Interventional Radiologist at Montgomery Radiology Associates, discusses this case further in an in-depth interview.

ReSolve ConvertX Tip

  • When placing bilaterally, ensure both systems are in place before stent conversion. If the first drain is converted to a stent before the second one is in place, it increases the risk of dislodging the first stent while placing the second.

Learn more about the advantages the ReSolve ConvertX can offer your patients and practice by visiting the product page or contacting the Merit Customer Support Center.

ClariVein® OC 5-Year Follow-up Results: Good Occlusion Rate, No Major Complications

Chronic venous insufficiency (CVI) in the legs, also known as varicose veins, is a relatively common condition, with worldwide prevalence ranging between 10% and 30%. Varicose veins can result in a number of symptoms, including pain, leg swelling, itching, and skin discoloration. Individuals with the condition may experience diminished quality of life and loss of work productivity. Finding treatment options that are effective and comfortable for the patient have been an area of interest in the endovascular community. ClariVein OC - treatment for endovenous mechanochemical ablation

A study by researchers in Verona, Italy, found that endovenous mechanochemical ablation (MOCA) treatment with the ClariVein® OC Infusion Catheter was associated with a good occlusion rate, comparable with other techniques, including thermal techniques, without major complications. This is one of the first reports in literature for MOCA treatment of symptomatic varicose veins with 5-year results. With little long-term data pertaining to this type of treatment, the aim of the study was to evaluate long-term occlusion rates.

This retrospective single-center study was published in Journal of Vascular Surgery: Venous and Lymphatic Disorders. Mirandola et al. treated 395 primary, symptomatic, unilateral, incompetent varicose saphenous veins in an outpatient setting. Of these patients, none were treated bilaterally in the same session. The majority of vessels treated were great saphenous veins (92.3%), and the others were small saphenous veins. Procedures were performed with the ClariVein OC and polidocanol 2% in liquid form.

A total of 329 patients were available for follow up, each treated between September 2012 and September 2017. Average follow-up time was 20 ± 18 months (range, 6-60 months). Results showed a technical success of 99.5%. Treatment was incomplete in two patients due to vein spasm, leading to catheter damage and inability to infuse the sclerosant. Follow up consisted of clinical evaluation and duplex ultrasound scan performed at 1 week, 1 month, 6 months, 1 year, and then once every year.

The overall survival rate free from recanalization was 92.4%. Anatomic success was 94% at 1 year, 91% at 2 years, 88% at 3 years, 88% at 4 years, and 84% at 5 years. The follow up at 5 years included 23 patients, five of whom presented with recanalization. The authors note that in this series, the veins completely disappeared on duplex ultrasound scan in 36% of cases.

It is interesting to note that after 89 patients, the researchers changed the way in which the sclerosant was injected. Beginning the infusion of sclerosant at point of mechanical pullback (protocol 2) produced higher occlusion rates compared to traditional ClariVein OC technique (protocol 1) with delayed infusion of sclerosant. Protocol 2 resulted in a change in cumulative survival rate free from recanalization from 92% to 97% (P ¼ 0.013).

Difference in anatomic success between 2 different protocolsFig 4. Difference in anatomic success between the two different protocols.

The researchers concluded that the ClariVein OC was associated with a good occlusion rate and was comparable with other techniques, including thermal techniques, without major complications.

Varicose veins occur when vessels are unable to pump blood back to the heart, causing the blood to pool, resulting in vessel enlargement over time. Under normal conditions, blood moves from the heart to the legs through the arteries and back to the heart through the veins. To accomplish this, the veins rely on surrounding muscles and a collection of valves to prevent blood from flowing backward. When these muscles and valves weaken or fail to work, blood begins to gather in the vein instead of returning to the heart.

In addition to pain, swelling, itching, and skin discoloration, other symptoms of varicose veins include:

  • Twisted and bulging veins
  • Aching, burning, throbbing and muscle cramping
  • Leg heaviness and fatigue

The ClariVein OC alleviates these symptoms by combining the power of a specialty infusion catheter with a rotating wire tip designed for the controlled 360-degree dispersion of physician-specified agents inside the targeted vessel. Requiring only a pin-sized entry through the skin, treatment with the ClariVein OC takes very little time, uses no heat or tumescent anesthesia, and creates minimal discomfort to the patient.

Learn more about the clinically proven ClariVein OC and how it can change the lives of your patients. Visit ClariVein.com or contact our Customer Support for more information.


IMPORTANT: This product page is intended only for an audience outside of the United States, as ClariVein OC is not approved, cleared, or available for sale in the United States. This product is not approved, cleared, or available for sale or use in the United States, and may not be approved, cleared, or available for sale or use in other countries. Please check with your country representative to determine which ClariVein catheters are available in your country. Please consult the product Instructions for Use (IFU) for indications, contraindications, potential complications, warnings, precautions, and directions for use.

ARTICLE REFERENCED:

Mirandola M et al. 2020. “An Italian Experience with Mechanochemical Ablation of the Saphenous Vein Since 2012.” J Vasc Surg Venous Lymphat Disord 8, no 6 (Nov): 999–1005. PMID: 32179039.

Meet the One-Vac™, Merit’s Newest Evacuated Drainage Bottle

One-Vac Evacuated Drainage Bottle - Merit MedicalMerit Medical is proud to announce the launch of the One-Vac Evacuated Drainage Bottle, the latest in evacuated drainage bottle technology. The smart option to aspirate, remove, or sample percutaneous fluids, the One-Vac is engineered with an advanced design that makes collection and discard simple, efficient, and safe.

The One-Vac is a valued addition to Merit’s Drainage portfolio and accompanies other premier products, such as the Aspira® Drainage System. This extension of the Drainage portfolio is the result of Merit’s commitment to continued innovation and dedication to providing clinicians with multiple high-quality product options when treating patients.

Read the press release.

Several key features are designed to make the One-Vac easy to use, helping to reduce the occurrence of common issues associated with bottle use.

One-Vac Bottle has a number of design features that will provide lasting benefits to you and your patients

KEY FEATURES & BENEFITS

1 – Ergonomic Handle
Start, stop, and regulate flow. Easy to remove, minimizing spills during discard.

2 – Easy Sampling
Connect syringe and open handle to remove fluid for sampling.

3 – Bottle Neck
Easy to hold.

4 – Durable Plastic
Designed to prevent breakage.

5 – Faster Flow Rates
Provides 68% faster flow rates than competitive evacuated bottles.1

Learn more about the One-Vac Evacuated Drainage Bottle by exploring its product page or by connecting with our Customer Support Center to see how you can incorporate it and other Merit solutions into your practice today.


Before using, refer to the product Instructions for Use (IFU) for indications, contraindications, potential complications, warnings, precautions, and directions for use.

REFERENCES

1. Data on file.

Embosphere® Results in Less Inflammatory Response, Lower Rates of Analgesic Use Compared to PVA After UFE

Every July, our team at Merit Medical recognizes Fibroid Awareness Month as a time to bring attention to a very common yet under-discussed condition that will affect most women at some point in their lifetime.

We do this by supporting a minimally invasive fibroid treatment called uterine fibroid embolization (UFE), also called uterine artery embolization (UAE), through a portfolio of embolotherapy products we offer.

Uterine Fibroid Embolization - Embosphere MicrospheresTo shed light on the performance of UFE embolic agents and to help physicians ensure women receive the best fibroid treatment experience possible, a randomized controlled trial by Han et al. compared post-UFE pain using nonspherical polyvinyl alcohol (PVA) particles versus Merit Medical’s Embosphere® Microspheres.

Published in Radiology, the study enrolled 54 women with fibroids (mean age, 44 ± 4 years [standard deviation]) and assigned UFE treatment with either nonspherical PVA (355–550 μm) or Embosphere (500–700 μm). There were 27 women in each group, and both participants and investigators collecting data were blinded to the embolic material used. Women with concomitant disease (e.g., adenomyosis) were excluded from the study.

Both groups were given fentanyl-based intravenous patient-controlled analgesia within the first 24 hours after UFE as well as rescue analgesics. The investigators measured neutrophil-to-lymphocyte ratio to assess inflammatory response, and contrast-enhanced MRI was performed 1 day after the procedure to evaluate dominant fibroid necrosis and ischemia of normal myometrium. Symptom severity score and health-related quality-of-life score were assessed before and 3 months after UFE.

Results showed that pain scores and fentanyl dose were not different during the first 24 hours, but the use of rescue analgesics was higher in the PVA group (33% vs 11%; P = 0.049). After embolization, symptom severity score and health-related quality-of-life score were not different between groups (symptom severity score: 16 [interquartile range, 6–22] for PVA vs 19 [interquartile range, 9–34] for Embosphere, P = .45; health-related quality-of-life score: 93 [interquartile range, 80–97] for PVA vs 89 [interquartile range, 84–96] for Embosphere, P = .41).

In addition, changes in neutrophil-to-lymphocyte ratio from before to 24 hours after UFE were greater in the PVA group (3.9 [interquartile range, 2.7–6.8] compared to the Embosphere group (2.5 [interquartile range, 1.5–4.6]; P = .02). Rates of complete dominant fibroid necrosis were not different between groups, but transient global uterine ischemia of normal myometrium was more frequent in the PVA group (44% vs 15%; P = .04).

The investigators of the study concluded that when used in UFE, PVA particles and Embosphere resulted in similar pain scores and fentanyl dose. However, PVA resulted in a greater inflammatory response, higher rates of rescue analgesic use, and more frequent transient global uterine ischemia compared to Embosphere.

Watch How UFE Works

Fibroids (also known as uterine fibroids, leiomyomas, and myomas) are non-cancerous tumors that grow within the muscle tissue of the uterus. Although some fibroids cause no symptoms at all, common symptoms can include excessive menstrual bleeding, pelvic pain and pressure, and frequent urination. Depending on the size and location of the fibroids, other symptoms can include anemia, leg pain, pain during sexual intercourse, constipation, and an enlarged abdomen. Up to 80% of women develop fibroids by the time they reach age 50.

Approximately, 600,000 hysterectomies are performed in the US each year, with fibroids listed as the most common reason. A report by the Society of Interventional Radiology found that 1 in 5 women believe hysterectomy is the only treatment option for fibroids and that 44% of women with fibroids have never heard of UFE. Although hysterectomy is a treatment for fibroids, there are many other treatment options available, many of which are minimally invasive.

44% of women have never heard of Uterine Fibroid Embolization

To encourage women to seek out all treatment options and help physicians educate patients, we offer an educational patient-awareness site called Ask4UFE with information about treatment options—with focus on UFE—as well as patient and physician testimonials and researched blog entries.

Join us in recognizing July as Fibroid Awareness Month. We look forward to working together to increase awareness surrounding the condition, helping to provide the best resources, products, and care for patients worldwide.


Before using, refer to Instructions for Use (IFU) for indications, contraindications, warnings, precautions, and directions for use.


ARTICLE REFERENCE
Han K et al. 2020. “Nonspherical Polyvinyl Alcohol Particles verusus Tris-Acryl Microspheres.” Radiology 298, no. 2 (Feb): 458–465. PMID: 33350893.

Merit Brings Awareness to Men’s Health During the Month of June

Merit Medical Brings Awareness to Men's HealthIt’s June and officially Men’s Health Month, a time dedicated to the raising awareness of health issues that affect men and boys, encouraging early detection and treatment of these conditions.

At Merit Medical, it’s our goal to not only provide the tools physicians need to treat and improve patient outcomes but also share knowledge and increase awareness surrounding risk factors for disease.

We understand that illness affects both men and women, but to offer the best patient care, it’s also important to shed light on diseases that are more prevalent in one sex versus the other.

Here are just some of the illnesses that are seen more frequently among men—and how we help care for each.

ESOPHAGEAL CANCER

Esophageal cancer is cancer found in the esophagus—the hollow, muscular tube in your body that carries food and liquid from the throat to the stomach. Men are around three times more likely than women to have esophageal cancer.

Esophageal CancerPrevention tips:

  • Avoid alcohol.
  • Eat more fruits and vegetables.
  • Maintain a healthy weight.
  • Exercise regularly.

Learn more about esophageal cancer.


MERIT PRODUCTS



LUNG CANCER

Lung cancer is a type of cancer that begins in the lungs. It is the leading cause of cancer deaths worldwide. The overall chance of a man developing lung cancer in his lifetime is approximately 1 in 15, whereas for a woman, the risk is about 1 in 17.

Lung Cancer Prevention TipsPrevention tips:

  • Quit smoking (or don’t start).
  • Stay away from secondhand smoke.
  • Test your home for radon.
  • Avoid cancer-causing chemicals.
  • Live a healthy lifestyle.

Learn more about lung cancer.


MERIT PRODUCTS



KIDNEY FAILURE

Although more women than men are diagnosed with chronic kidney disease, or CKD, men are more likely to reach kidney failure sooner.

Although kidney failure can happen to anyone, men may be more at risk compared to women due to differences in hormones and living unhealthier lifestyles.

Think Dialysis Access Merit Physician CoursePrevention Tips:

  • Get a kidney check-up at least every year.
  • Control your blood pressure and blood sugar.
  • Stop smoking (or don’t start).
  • Exercise and eat a healthy diet.
  • Maintain a healthy weight.
  • If you have an enlarged prostate, talk with your doctor to make sure it’s not blocking your urinary tract.
  • Give your doctor a list of any supplements, medicines, and/or hormone treatments you’re taking to ensure they aren’t damaging your kidneys.

Learn more about kidney failure and visit our Dialysis Access Solution page.


MERIT PRODUCTS



AORTIC ANEURYSM

The aorta runs from the heart through the center of the chest and abdomen. It’s the main blood vessel that brings blood to the abdomen, pelvis, and legs. An abdominal aortic aneurysm (AAA) is a life-threatening condition that occurs when the vessel enlarges, putting it at risk of bursting. Men are 4-15 times more likely to develop an AAA than women

Aortic AneurysmPrevention tips:

  • Stop smoking (or don’t start).
  • Reduce stress.
  • Exercise and eat a heart-healthy diet.
  • If you have diabetes or high blood pressure, take the medicines your doctor has prescribed.

Learn more about AAA. To learn more about our packs, wires, and other cardiac products, please visit our Merit Vascular page.


MERIT PRODUCTS



HEART ATTACK

heart attack, also known as a myocardial infarction, occurs when heart muscle doesn’t receive enough blood. As time passes without receiving treatment, the more damage is done to the heart. The main cause of a heart attack is coronary artery disease (CAD). Researchers have found that throughout life, men are about twice as likely as women to have a heart attack.

Heart Attack - Men's Health MonthPrevention Tips:

  • Eat a healthy diet.
  • Maintain a healthy weight.
  • Exercise regularly.
  • Stop smoking (or don’t start).
  • Monitor your cholesterol and blood pressure.
  • Manage your diabetes.
  • Take your prescribed medicines.

Learn more about heart attacks. Explore our Cardiac Portfolio, including our radial sheaths, catheters, wires, and compression devices.


MERIT PRODUCTS



LIVER CANCER

Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer and is most often seen in people with chronic liver diseases, such as cirrhosis caused by hepatitis B or hepatitis C. Worldwide, HCC is the fourth leading cause of cancer death and is 3 times more common among males than females.

Liver Cancer - Men's Health MonthPrevention Tips:

  • Avoid heavy alcohol use.
  • Reduce exposure to aflatoxin B1.
  • Stop smoking (or don’t start).
  • Get the hepatitis B vaccine.
  • If you have hepatitis, work with your care provider to receive treatment.

Learn more about liver cancer. Visit our Hepatic Oncology portfolio.


MERIT PRODUCTS



BENIGN PROSTATIC HYPERPLASIA (BPH)

Benign prostatic hyperplasia, or BPH, is the enlargement of the prostate gland and affects only men. It becomes more common as men get older. Up to 90% of men over the age of 80 have BPH. Although BPH is noncancerous, it can cause bothersome lower urinary tract symptoms.

BPH - Men's Health MonthPrevention Tips:

  • Maintain a heart-healthy diet.
  • Avoid heavy alcohol use.
  • Exercise regularly.

Explore the products we offer to support prostatic artery embolization (PAE), a minimally invasive option to treat BPH.


MERIT PRODUCTS



At Merit Medical, our goal is to improve the lives of people, families, and communities worldwide. An important part of this is caring for men’s health by providing the products and therapies needed for patients to live at their best.

Have questions? Reach out to our Customer Support team.


Before using, refer to Instructions for Use for indications, contraindications, warnings, precautions, and directions for use.

Merit Medical to Exhibit New Products and Must-See Educational Symposia During SIR 2021

Society of Interventional Radiology 2021 Meeting

Merit will be exhibiting at this year’s Society of Interventional Radiology (SIR) meeting held virtually from March 20-26. At the Merit virtual booth, we will showcase several innovative products—including the newly launched SplashWire™ Hydrophilic Steerable Guide Wire—and hold two must-see educational symposia.

Mark your calendars for the following events at our virtual booth:

March 20, Saturday

Calling all medical students, nurse practitioners, physician assistants, and residents! This is your chance to learn about our renowned Think Education program. Designed and taught by physicians, Think Education offers both training and clinical support needed to implement new tools and techniques into your practice. Explore upcoming courses.


March 21 - Celebrating Women in IR

March 21, Sunday

A day we dedicate to recognizing all the incredible women who work in interventional radiology and make a difference in patients’ lives each day.


March 22 - SplashWire

March 22, Monday

Have you met our latest guide wire? Stop by the Merit virtual booth to get a close-up of the SplashWire, designed to deliver superior performance in diagnostic and interventional procedures. See how it can help you traverse difficult lesions and support clinical outcomes in the most challenging procedures. Learn more about the new SplashWire.


March 23 - CorVocet

March 23, Tuesday

Familiarize yourself with the CorVocet, a biopsy system designed to cut a full core of tissue, providing large specimens for pathological examination. With a lightweight and ergonomic design, the CorVocet facilitates one-handed priming, positioning, and deployment, which can be beneficial during image-guided procedures. Discover the CorVocet.


March 24 - ConvertX

March 24, Wednesday

Stop by and learn about the Resolve ConvertX, a stent system used for temporary internal drainage in patients with ureteral or biliary obstructions. Learn how its technology provides a less invasive option by eliminating the need for a second interventional procedure. Explore the ConvertX.


SYMPOSIUM: Management of Venous Access in Patients with Central Venous Occlusions: Surfacer® Inside-Out® Access Catheter System

Surfacer Inside-Out Access System

DATE: Thursday, March 25
SPEAKER: Mahmood K. Razavi, MD
TIME: 7:10-7:50 pm ET

About the Product:
The Surfacer is a unique access catheter system designed to obtain right-sided central venous access in patients with venous obstructions. Learn more and watch how the Surfacer works here.


SYMPOSIUM: Arcadia: Next Generation Balloon-Assisted Vertebral Augmentation

DATE: Friday, March 26
SPEAKERS:David Shelley, MD
Douglas P. Beall, MD
Scott A. Koss, MD

TIME: 7:10-7:50 pm ET

About the Product:
Harnessing Merit Spine’s unique portfolio feature of steerability, the Arcadia is an intuitive balloon-assisted vertebral augmentation (kyphoplasty) system that allows for a bipedicular footprint through a unipedicular approach, offering several benefits when treating patients with painful benign or pathologic vertebral compression fractures. Learn more here.

Merit Recognizes National Kidney Month & World Kidney Day

National Kidney Month

National Kidney Month and World Kidney Day are here, and both are very important times we recognize at Merit Medical. All over the globe, you will find the Merit family raising awareness about kidney disease as well as continuing to ensure our dialysis products and education services are available to clinicians and their patients.

Kidney disease is a global issue. Approximately 2 million people worldwide suffer from kidney failure, and the number of patients diagnosed with the disease continues to increase at a rate of 5—7% per year.1 As many people worldwide currently receive treatment with dialysis or a kidney transplant to stay alive, yet this number may only represent 10% of people who actually need treatment to live.2

Through our dedication and the supportive programs, high-quality products, and services we provide, our team acts as an ambassador for better dialysis care. Here’s how.


OUR DEDICATION

Our Dialysis team is made up of expert clinical support specialists, sales representatives, portfolio managers, and more—all dedicated to ensuring our products and services are made available to the clinicians and patients who need them.

Wearing Green for National Kidney Month

OUR PRODUCTS

Hero Graft front cutaway diagram of graft insertion into patient

Our diverse portfolio of dialysis access products provides what clinicians need from stick to stitch.

This includes reliable hemodialysis options, such as the HeRO® Graft—the only fully subcutaneous AV access solution clinically proven to maintain long-term access for hemodialysis patients with central venous stenosis.

For peritoneal dialysis (PD) care, we offer state-of-the-art Flex-Neck® Peritoneal Dialysis Catheters. With a larger internal diameter over competitive catheters, Flex-Neck catheters allow for higher flow rates than other catheters on the U.S. market.3 Catheter Implantation Kits are also available, designed to streamline the implantation procedure and promote efficiency.

Clinicians can also choose from an assortment of other hemodialysis products, such as the Centros® Hemodialysis Catheters or ProGuide™ Chronic Dialysis Catheters as well as innovative renal accessories, such as the Slip-Not® Suture Retention Device.

Browse through our entire collection of Dialysis Access Solutions.


OUR SERVICES

Think Dialysis Access Merit Physician Course

Clinician Training

At Merit, our goal is to not only provide high-quality dialysis products but also offer the training and support needed for clinicians to give patients optimal dialysis care. In turn, we also offer helpful resources patients can use to familiarize themselves with all dialysis treatment options.

To adapt our training options during the pandemic, we offer a Virtual Percutaneous PD Webinar for physicians and a Virtual Dialysis Access CE Program for nurses, dialysis technicians, and other healthcare professionals.

Visit us here to register for these virtual training opportunities as well as learn about our Think Dialysis Access™ physician education program.

Clinical Case Support

To better aid clinicians in dialysis access cases, we also have a dedicated team of dialysis access clinical specialists who understand the intricacies of hemodialysis and PD and are ready to support. From explaining correct Merit product use to on-site troubleshooting, Merit clinical specialists are available to assist.

Patient Education: Ask4PD

A significant part of improving dialysis care is ensuring patients understand their treatment options. Ask4PD.com is a patient education site powered by Merit that’s dedicated to helping patients understand dialysis care, especially PD. Individuals have access to helpful resources, including patient and healthcare professional testimonials.


MORE RESOURCES

Learn more about kidney health, kidney disease, and treatment with these helpful resources:

This National Kidney Month, World Kidney Day, and every day, our team at Merit is dedicated to being your partner in providing better dialysis care.

Explore our complete Dialysis Access portfolio and connect with our Customer Support Center to see how you can incorporate these solutions into your dialysis practice today.


References

  1. University of California San Francisco. 2018. “The Kidney Project.” https://pharm.ucsf.edu/kidney/need/statistics
  2. National Kidney Foundation. n.d. “Global Facts: About Kidney Disease.” https://www.kidney.org/kidneydisease/global-facts-about-kidney-disease#:~:text=Over%202%20million%20people%20worldwide,actually%20need%20treatment%20to%20live.
  3. Katzman HE et al. 2009. “Initial Experience and Outcome of a New Hemodialysis Access Device for Catheter-Dependent Patients. J Vasc Surg Sep;50(3):600-607

New SplashWire™ Delivers Superior Performance in Diagnostic and Interventional Procedures

Merit Medical is proud to announce the launch of the SplashWire™, a hydrophilic steerable guide wire designed to facilitate the placement of devices during diagnostic and interventional procedures. The SplashWire is the result of Merit’s commitment to continued innovation and dedication to making superior products that meet the specific needs of physicians.

A number of key features enable the SplashWire to attenuate common issues associated with guide wire use—such as wire whipping and friction—as well as promote rapid catheter exchanges, all helping to traverse difficult lesions and support successful clinical outcomes in the most challenging procedures.


KEY FEATURES

Resilient Hydrophilic Coating—Provides a constant lubricity that’s superior to the market-leading hydrophilic guide wire,1 enhancing lesion crossability and reducing friction and insertion forces when traversing complex lesions.

Tungsten-Infused Polymer Jacket—Combined with the nitinol core wire, boosts visualization under fluoroscopy for accurate positioning.

Multiple Configurations—For added procedural flexibility, the SplashWire is available in many diameters, lengths, and angled and straight configurations.

Stiff Configuration—Offers more support and pushability.

Nitinol Core—Delivers kink resistance and true 1:1 torque response for smooth navigation in tortuous vessels.1

SPLASHWire Torque Response Comparison Chart

Comparative torque testing1 shows the SplashWire consistently meets the 1:1 torque target, unlike the market leader’s exaggerated torque response. As displayed in the chart, bars closest to the target line indicate true 1:1 torqueability.

Stiff Configuration
Nitinol Core
Resilient Hydrophilic Coating

The SplashWire is a valued addition to the Merit Angiography portfolio, a compilation of tools developed by applying physician feedback, investing in new technologies, and improving upon legacy products. This dedication to continued innovation and ongoing excellence has resulted in products that deliver superior performance for diagnostic and interventional procedures.

Learn more about the SplashWire Hydrophilic Steerable Guide Wire by exploring its product page or by connecting with our Customer Support Center to see how you can incorporate it and other Merit solutions into your practice today.


References

1. Test data on file.

ClariVein® OC Provides Varicose Vein Relief, Less Pain Than Radiofrequency Ablation, Similar Quality of Life Outcomes

Varicose veins are a common condition worldwide. Currently estimated to affect up to 3 in 10 adults,1 varicose veins are responsible for significantly diminished quality of life with consequent healthcare costs.2

To treat varicose veins, endovenous thermal ablation has been considered the gold standard of care—but this technique is not without patient discomfort. In recent years, new therapies have been developed and research implemented in an effort to improve the treatment experience for patients with varicose veins.

A multi-centre randomized controlled trial2 by researchers at Imperial College London and London North West Hospitals NHS Trust found that compared with radiofrequency ablation—a type of endovenous thermal ablation—treatment with minimally invasive ClariVein OC was less painful and produced similar short-term results as well as quality of life and safety outcomes.

The study,2 published in Phlebology, recruited 170 patients and randomly assigned them to undergo either radiofrequency ablation or treatment with ClariVein OC. Researchers examined pain scores using a Visual Analogue Scale (VAS) and number scale (0 ̶ 10) during treatment. Patients were followed up at one and six months with clinical scores, quality of life scores, and ultrasound assessment of the treated leg.

Venefit versus ClariVein OC for varicose veins consort diagram.

Results2 showed that patients in the ClariVein OC group experienced significantly less pain during the procedure by both VAS (ClariVein OC median 15 mm [IQR 7–36 mm] vs. radiofrequency ablation 34 mm [IQR 16–53 mm], p = 0.003) and number scale (ClariVein OC median 3 [IQR 1–5] vs. radiofrequency ablation 4 [IQR 3–6.5], p = 0.002).

Data2 also showed that average pain scores were significantly less in the ClariVein OC group (VAS median 10 mm [3–25 mm] vs. 19.5 mm [9–38 mm], p = 0.003, Mann-Whitney, and number scale median of 2 [0.5–4] versus 3 [2–5], p = 0.004, Mann Whitney).

Occlusion rates, clinical severity scores, disease specific and generic quality of life scores were similar between groups at one and six months.2 Overall, patients returned to work and normal activities at a median of two days (IQR 2–7 and 1–6, respectively). Adverse events included two deep vein thromboses, one in each group.

The researchers concluded2 that treatment for varicose veins is less painful with ClariVein OC than radiofrequency ablation with similar short-term technical, quality of life, and safety outcomes.  Clinical outcomes and time returning to work and normal activities were all similar. These findings support other data comparing patient pain between ClariVein OC and radiofrequency ablation3 as well as published five-year follow-up data examining ClariVein OC’s long-term efficacy.4

Results2 showed that patients in the ClariVein OC group experienced significantly less pain during the procedure by both VAS (ClariVein OC median 15 mm [IQR 7–36 mm] vs. radiofrequency ablation 34 mm [IQR 16–53 mm], p = 0.003) and number scale (ClariVein OC median 3 [IQR 1–5] vs. radiofrequency ablation 4 [IQR 3–6.5], p = 0.002).

Data2 also showed that average pain scores were significantly less in the ClariVein OC group (VAS median 10 mm [3–25 mm] vs. 19.5 mm [9–38 mm], p = 0.003, Mann-Whitney, and number scale median of 2 [0.5–4] versus 3 [2–5], p = 0.004, Mann Whitney).

Occlusion rates, clinical severity scores, disease specific and generic quality of life scores were similar between groups at one and six months.2 Overall, patients returned to work and normal activities at a median of two days (IQR 2–7 and 1–6, respectively). Adverse events included two deep vein thromboses, one in each group.

The researchers concluded2 that treatment for varicose veins is less painful with ClariVein OC than radiofrequency ablation with similar short-term technical, quality of life, and safety outcomes.  Clinical outcomes and time returning to work and normal activities were all similar. These findings support other data comparing patient pain between ClariVein OC and radiofrequency ablation3 as well as published five-year follow-up data examining ClariVein OC’s long-term efficacy.4

Figure 2. Maximum pain score during procedure for mechanochemical ablation group (MOCA) and radiofrequency ablation (RFA) (a) – visual analogue scale and (b) – number scale.

Varicose veins can be unsightly and for some patients cause discomfort. The underlying cause of varicose veins is venous reflux disease, which occurs when the valves inside veins become weakened or damaged. When this happens, blood flows backwards and collects inside the vein, causing it to enlarge. Varicose veins are most common in the legs and feet. Left untreated, venous reflux disease can progress to create other more serious circulatory and skin problems.

To treat varicose veins, radiofrequency ablation uses imaging guidance to navigate a small catheter into the diseased vein to deliver heat, causing vessel walls to collapse and close. Although considered effective, radiofrequency ablation requires the use of tumescent anaesthesia which involves multiple needle injections.

In contrast, ClariVein OC combines the power of a specialty infusion catheter with a rotating wire tip designed for the controlled 360-degree dispersion of physician-prescribed medication inside the targeted vessel. Requiring only a pin-sized entry through the skin, treatment with the ClariVein OC takes very little time, uses no heat or tumescent anaesthesia, and creates minimal discomfort to the patient.

Learn more about the clinically proven ClariVein OC and how it can change the lives of your patients. Visit ClariVein.com or contact our Customer Support for more information.


IMPORTANT

This product page is intended only for an audience outside of the United States, as ClariVein OC is not approved, cleared, or available for sale in the United States. This product is not approved, cleared, or available for sale or use in the United States, and may not be approved, cleared, or available for sale or use in other countries.

Please check with your country representative to determine which ClariVein catheters are available in your country.

Please consult the product Instructions for Use (IFU) for indications, contraindications, potential complications, warnings, precautions, and directions for use.


References

  1. NHS Inform. 13 February 2020. “Varicose Veins.” https://www.nhsinform.scot/illnesses-and-conditions/heart-and-blood-vessels/conditions/varicose-veins
  2. Lane et al. 2016. “A Multi-Centred Randomised Controlled Trial Comparing Radiofrequency and Mechanical Occlusion Chemically Assisted Ablation of Varicose Veins—Final Results of the Venefit versus ClariVein for Varicose Veins Trial.” Phlebology 32, no. 2 (March): 89–98. PMID: 27221810.
  3. Vun et al. 2015. “Lower Pain and Faster Treatment with Mechanico-Chemical Endovenous Ablation Using ClariVein®.” Phlebology 30, no 10 (Dec): 688–692. PMID: 25300311.
  4. Mirandola et al. 2020. “An Italian Experience with Mechanochemical Ablation of the Saphenous Vein Since 2012.” J Vasc Surg Venous Lymphat Disord 8, no 6 (Nov): 999–1005. PMID: 32179039.
logo